**Figure 3. Olaparib sensitivity after depletion of EWS-FLI1 from A673 cells.** **(A)** Cell viability assays were performed with the indicated doses of olaparib, or an equivalent volume of vehicle control (DMSO). Relative viability was calculated as a percentage of untreated cells. **(B)** siRNA-mediated depletion of EWS-FLI1 was determined after 72 hr treatment with vehicle control (DMSO) or olaparib. Relative expression levels of EWS-FLI1 expression normalized to RPLP0 (ribosomal protein lateral stalk subunit P0) was determined by qRT-PCR. Expression level of siCT cells treated with DMSO was assigned a value of 100. Access the [full size image][1] and [R script][2] used to generate this figure. <br> **Figure 3 - figure supplement 1. Cell viability assays for each biological repeat.** This is the same experiment as in Figure 3. The line graph of each biological repeat is plotted individually. Access the [full size image][3] and [R scripts][4] that were used to generate this figure. [1]: https://osf.io/fst65/ [2]: https://osf.io/7ek3g/ [3]: https://osf.io/ep7bj/ [4]: https://osf.io/h8rj4/